Logo image of CS.CA

CAPSTONE COPPER CORP (CS.CA) Stock Fundamental Analysis

TSX:CS - Toronto Stock Exchange - CA14071L1085 - Common Stock - Currency: CAD

6.72  +0.08 (+1.2%)

Fundamental Rating

5

Overall CS gets a fundamental rating of 5 out of 10. We evaluated CS against 811 industry peers in the Metals & Mining industry. While CS belongs to the best of the industry regarding profitability, there are concerns on its financial health. CS is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year CS was profitable.
CS had a positive operating cash flow in the past year.
CS had positive earnings in 4 of the past 5 years.
CS had a positive operating cash flow in each of the past 5 years.
CS.CA Yearly Net Income VS EBIT VS OCF VS FCFCS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

CS's Return On Assets of 1.30% is amongst the best of the industry. CS outperforms 86.93% of its industry peers.
Looking at the Return On Equity, with a value of 2.71%, CS belongs to the top of the industry, outperforming 88.41% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.82%, CS belongs to the top of the industry, outperforming 89.15% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CS is significantly below the industry average of 24.67%.
The 3 year average ROIC (1.34%) for CS is below the current ROIC(1.82%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.3%
ROE 2.71%
ROIC 1.82%
ROA(3y)0.61%
ROA(5y)3.18%
ROE(3y)1.11%
ROE(5y)5.45%
ROIC(3y)1.34%
ROIC(5y)3.44%
CS.CA Yearly ROA, ROE, ROICCS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

CS has a Profit Margin of 5.18%. This is amongst the best in the industry. CS outperforms 91.37% of its industry peers.
In the last couple of years the Profit Margin of CS has declined.
Looking at the Operating Margin, with a value of 10.24%, CS belongs to the top of the industry, outperforming 90.51% of the companies in the same industry.
CS's Operating Margin has improved in the last couple of years.
The Gross Margin of CS (13.42%) is better than 86.44% of its industry peers.
In the last couple of years the Gross Margin of CS has grown nicely.
Industry RankSector Rank
OM 10.24%
PM (TTM) 5.18%
GM 13.42%
OM growth 3Y-32.62%
OM growth 5Y23.43%
PM growth 3Y-43.37%
PM growth 5YN/A
GM growth 3Y-33.56%
GM growth 5Y5.61%
CS.CA Yearly Profit, Operating, Gross MarginsCS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CS is destroying value.
Compared to 1 year ago, CS has more shares outstanding
The number of shares outstanding for CS has been increased compared to 5 years ago.
CS has a better debt/assets ratio than last year.
CS.CA Yearly Shares OutstandingCS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CS.CA Yearly Total Debt VS Total AssetsCS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CS has an Altman-Z score of 1.04. This is a bad value and indicates that CS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.04, CS perfoms like the industry average, outperforming 50.92% of the companies in the same industry.
CS has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
CS has a worse Debt to Equity ratio (0.42) than 71.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z 1.04
ROIC/WACC0.23
WACC7.85%
CS.CA Yearly LT Debt VS Equity VS FCFCS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

CS has a Current Ratio of 0.79. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CS (0.79) is worse than 62.39% of its industry peers.
CS has a Quick Ratio of 0.79. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.49, CS is not doing good in the industry: 66.34% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.49
CS.CA Yearly Current Assets VS Current LiabilitesCS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

CS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 174.22%, which is quite impressive.
The earnings per share for CS have been decreasing by -46.87% on average. This is quite bad
CS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.86%.
CS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.74% yearly.
EPS 1Y (TTM)174.22%
EPS 3Y-46.87%
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)18.86%
Revenue growth 3Y26.25%
Revenue growth 5Y30.74%
Sales Q2Q%26.35%

3.2 Future

The Earnings Per Share is expected to grow by 42.25% on average over the next years. This is a very strong growth
CS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.20% yearly.
EPS Next Y239.9%
EPS Next 2Y165.99%
EPS Next 3Y113.56%
EPS Next 5Y42.25%
Revenue Next Year31.28%
Revenue Next 2Y25.75%
Revenue Next 3Y21.41%
Revenue Next 5Y15.2%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CS.CA Yearly Revenue VS EstimatesCS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
CS.CA Yearly EPS VS EstimatesCS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4 0.6 0.8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 56.00 indicates a quite expensive valuation of CS.
87.05% of the companies in the same industry are more expensive than CS, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.75. CS is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 15.88, which indicates a correct valuation of CS.
90.75% of the companies in the same industry are more expensive than CS, based on the Price/Forward Earnings ratio.
CS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.49, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 56
Fwd PE 15.88
CS.CA Price Earnings VS Forward Price EarningsCS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CS is valued cheaper than 91.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.18
CS.CA Per share dataCS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

CS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CS has an outstanding profitability rating, which may justify a higher PE ratio.
CS's earnings are expected to grow with 113.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y165.99%
EPS Next 3Y113.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAPSTONE COPPER CORP

TSX:CS (5/1/2025, 7:00:00 PM)

6.72

+0.08 (+1.2%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-01 2025-05-01
Inst Owners30.49%
Inst Owner ChangeN/A
Ins Owners2.66%
Ins Owner ChangeN/A
Market Cap5.12B
Analysts84
Price Target11.64 (73.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-31.66%
Min EPS beat(2)-36.79%
Max EPS beat(2)-26.52%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-11.29%
Min Revenue beat(2)-13.64%
Max Revenue beat(2)-8.94%
Revenue beat(4)0
Avg Revenue beat(4)-7.65%
Min Revenue beat(4)-13.64%
Max Revenue beat(4)-3.49%
Revenue beat(8)1
Avg Revenue beat(8)-6.17%
Revenue beat(12)4
Avg Revenue beat(12)2.03%
Revenue beat(16)7
Avg Revenue beat(16)3.19%
PT rev (1m)-8.4%
PT rev (3m)-13.94%
EPS NQ rev (1m)-11.38%
EPS NQ rev (3m)-62.94%
EPS NY rev (1m)-0.74%
EPS NY rev (3m)-49.05%
Revenue NQ rev (1m)-0.83%
Revenue NQ rev (3m)-16.76%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)-6.35%
Valuation
Industry RankSector Rank
PE 56
Fwd PE 15.88
P/S 2.32
P/FCF N/A
P/OCF 9.29
P/B 1.21
P/tB 1.21
EV/EBITDA 10.18
EPS(TTM)0.12
EY1.79%
EPS(NY)0.42
Fwd EY6.3%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.72
OCFY10.77%
SpS2.9
BVpS5.54
TBVpS5.54
PEG (NY)0.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.3%
ROE 2.71%
ROCE 2.89%
ROIC 1.82%
ROICexc 1.86%
ROICexgc 1.86%
OM 10.24%
PM (TTM) 5.18%
GM 13.42%
FCFM N/A
ROA(3y)0.61%
ROA(5y)3.18%
ROE(3y)1.11%
ROE(5y)5.45%
ROIC(3y)1.34%
ROIC(5y)3.44%
ROICexc(3y)1.38%
ROICexc(5y)3.97%
ROICexgc(3y)1.38%
ROICexgc(5y)3.97%
ROCE(3y)2.11%
ROCE(5y)5.36%
ROICexcg growth 3Y-48.8%
ROICexcg growth 5Y18.97%
ROICexc growth 3Y-48.8%
ROICexc growth 5Y18.97%
OM growth 3Y-32.62%
OM growth 5Y23.43%
PM growth 3Y-43.37%
PM growth 5YN/A
GM growth 3Y-33.56%
GM growth 5Y5.61%
F-Score7
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Debt/EBITDA 2.7
Cap/Depr 141.71%
Cap/Sales 28.02%
Interest Coverage 5.29
Cash Conversion 83.06%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.49
Altman-Z 1.04
F-Score7
WACC7.85%
ROIC/WACC0.23
Cap/Depr(3y)239.93%
Cap/Depr(5y)196.04%
Cap/Sales(3y)39.01%
Cap/Sales(5y)31.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)174.22%
EPS 3Y-46.87%
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y239.9%
EPS Next 2Y165.99%
EPS Next 3Y113.56%
EPS Next 5Y42.25%
Revenue 1Y (TTM)18.86%
Revenue growth 3Y26.25%
Revenue growth 5Y30.74%
Sales Q2Q%26.35%
Revenue Next Year31.28%
Revenue Next 2Y25.75%
Revenue Next 3Y21.41%
Revenue Next 5Y15.2%
EBIT growth 1Y370.19%
EBIT growth 3Y-14.94%
EBIT growth 5Y61.37%
EBIT Next Year243.58%
EBIT Next 3Y85.86%
EBIT Next 5Y49.63%
FCF growth 1Y90.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y241.25%
OCF growth 3Y-10.35%
OCF growth 5Y33.82%